Related Experiment Video
Updated: Jan 12, 2026

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model
Published on: October 3, 2011
Application of Hypoxia-Activated Prodrugs in Tumor Therapy: Design Strategies and Perspectives
Shengyu Liu1, Mijia Zhang1, Xiangxi Sun1
1Hebei University of Science and Technology, Shijiazhuang 050018, People's Republic of China.
Abstract:
Hypoxia is one of the common characteristics of solid tumors, primarily resulting from an imbalance between rapid tumor proliferation and disordered angiogenesis. Hypoxic heterogeneity promotes tumor invasion and metastasis, metabolic reprogramming, immune suppression, and angiogenesis. Moreover, tumor hypoxia is one of the major drivers of widespread drug resistance observed in cancer therapy. Hypoxia also presents opportunities for targeted tumor therapy with hypoxia-targeted prodrugs (HAPs) showing great potential in cancer treatment. This perspective summarizes the fundamental principles, major classifications, and drug design strategies of HAPs, as well as highlights the innovative integration of HAPs with other therapeutic modalities. This article endeavors to provide a comprehensive perspective on the evolving field of hypoxia-targeting agents, offering valuable insights into future drug development.
More Related Videos
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Prodrugs
Prodrugs help overcome...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

